Compare Aecom (ACM) vs Adaptive Biotechnologies Corp (ADPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aecom vs Adaptive Biotechnologies Corp — how do they compare? Aecom trades at $67.07 (market cap $8.62B), while Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B). The key difference: Aecom is far larger — about 2.1× Adaptive Biotechnologies Corp's market cap, and Aecom pays a 1.77% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ACM | ADPT | |
|---|---|---|
Market Cap | $8.62B | $4.04B |
Sector | Industrials | Health |
52-Week High | $134.35 | $25.45 |
52-Week Low | $66.86 | $12.30 |
Enterprise Value | $10.81B | $4.10B |
Dividend Yield | 1.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Aecom
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →
